Further, Insulet has achieved several milestones with respect to expanding Omnipod’s market access. The company launched the Omnipod DASH system in the United States in 2019. In 2020, the ...

Omnipod DASH continues to be the leading insulin pump offer with an indication for use in the Type 2 market. While the company is yet to progress with Omnipod 5 AID in the Type 2 market, the ...

The Omnipod DASH System, which received FDA clearance in June 2018, is the only DTSec and ISO 27001 certified insulin pump for cyber and information security and safety. About Insulet Corporation: ...

According to the HHS’ database, the cybersecurity incident spans around 29,000 Omnipod Dash users. The Omnipod Dash device is a simplified version of Insulet’s flagship Omnipod 5 pump.

Insulet plans to launch the Omnipod DASH System throughout Canada on a province-by-province basis throughout 2021 to coincide with reimbursement by provincial health programs.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of an issue with the Omnipod ...